Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Health Occupations > Medicine > Public Health > Epidemiologic Methods > Epidemiologic Study Characteristics > Clinical Studies as Topic > Clinical Trials as Topic > Clinical Trials, Phase II as Topic
... > Environment and Public Health > Public Health > Epidemiologic Methods > Epidemiologic Study Characteristics > Clinical Studies as Topic > Clinical Trials as Topic > Clinical Trials, Phase II as Topic
... > Population Characteristics > Health > Public Health > Epidemiologic Methods > Epidemiologic Study Characteristics > Clinical Studies as Topic > Clinical Trials as Topic > Clinical Trials, Phase II as Topic
... > Investigative Techniques > Epidemiologic Methods > Epidemiologic Study Characteristics > Clinical Studies as Topic > Clinical Trials as Topic > Clinical Trials, Phase II as Topic
... > Health Care Quality, Access, and Evaluation > Quality of Health Care > Health Care Evaluation Mechanisms > Epidemiologic Study Characteristics > Clinical Studies as Topic > Clinical Trials as Topic > Clinical Trials, Phase II as Topic
... > Health Occupations > Health Services Administration > Quality of Health Care > Health Care Evaluation Mechanisms > Epidemiologic Study Characteristics > Clinical Studies as Topic > Clinical Trials as Topic > Clinical Trials, Phase II as Topic

Preferred term

Clinical Trials, Phase II as Topic  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Drug Evaluation, FDA Phase II as Topic
  • Evaluation Studies, FDA Phase II as Topic

Note

  • for general design, methodology, economics, etc. of phase II clinical trials; a different heading CLINICAL TRIAL, PHASE II is used for reports of a specific phase II clinical trial

Scope note

  • Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.

History note

  • 2008(1993)

In other languages

URI

http://www.yso.fi/onto/mesh/D017322

Download this concept:

RDF/XML TURTLE JSON-LD Created 5/13/92, last modified 6/29/18